Heramed Ltd - Asset Resilience Ratio

Latest as of December 2024: 0.83%

Heramed Ltd (HMD) has an Asset Resilience Ratio of 0.83% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HMD working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$23.01K
≈ $16.28K USD Cash + Short-term Investments

Total Assets

AU$2.78 Million
≈ $1.96 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Heramed Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Heramed Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Heramed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Heramed Ltd total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$23.01K 0.83%
Total Liquid Assets AU$23.01K 0.83%

Asset Resilience Insights

  • Limited Liquidity: Heramed Ltd maintains only 0.83% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Heramed Ltd Industry Peers by Asset Resilience Ratio

Compare Heramed Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medtronic plc
SA:MDTC34
Medical Devices 7.82%
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Medartis Holding AG
SW:MED
Medical Devices 0.00%
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Mediantechn
PA:ALMDT
Medical Devices 0.45%

Annual Asset Resilience Ratio for Heramed Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Heramed Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.83% AU$23.01K
≈ $16.28K
AU$2.78 Million
≈ $1.96 Million
-0.63pp
2023-12-31 1.46% AU$29.38K
≈ $20.79K
AU$2.01 Million
≈ $1.43 Million
+0.92pp
2022-12-31 0.54% AU$22.51K
≈ $15.93K
AU$4.19 Million
≈ $2.96 Million
-0.01pp
2021-12-31 0.55% AU$25.27K
≈ $17.88K
AU$4.57 Million
≈ $3.24 Million
-0.68pp
2020-12-31 1.23% AU$39.06K
≈ $27.64K
AU$3.17 Million
≈ $2.25 Million
+0.22pp
2019-12-31 1.02% AU$36.61K
≈ $25.90K
AU$3.61 Million
≈ $2.55 Million
+0.85pp
2018-12-31 0.16% AU$6.86K
≈ $4.85K
AU$4.27 Million
≈ $3.02 Million
-0.24pp
2017-12-31 0.40% AU$5.00K
≈ $3.53K
AU$1.25 Million
≈ $882.84K
--
pp = percentage points

About Heramed Ltd

AU:HMD Australia Medical Devices
Market Cap
$33.10 Million
AU$46.77 Million AUD
Market Cap Rank
#23522 Global
#895 in Australia
Share Price
AU$0.04
Change (1 day)
+2.44%
52-Week Range
AU$0.03 - AU$0.05
All Time High
AU$0.32
About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more